← Leaderboards
Matthew S. Gentry
University Of Florida
$17,365,380
Attributed
$19,211,257
Total exposure
13
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.4M · FY2007–25$5M$3.8M$2.5M$1.3M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$26,542,071 · 14
By mechanism
P01$9,975,342 · 4
R35$7,179,367 · 1
R01$6,926,900 · 3
R33$751,062 · 1
R00$695,505 · 1
P20$477,473 · 2
Top collaborators
- Ramon C. Sun7 shared
- James R Pauly1 shared
Others in their field
Top investigators on “Glycogen”
- Peter J Roach · Indiana Univ-Purdue Univ At Indianapolis$14,912,461
- Dwight D Koeberl · Duke University$10,403,079
- Peter S Klein · University Of Pennsylvania$10,135,315
- Richard S Jope · University Of Alabama At Birmingham$9,093,701
- Alan D Cherrington · Vanderbilt University$8,845,730
- David H Perlmutter · Washington University$8,796,369
Research focus
GlycogenGlycogen MetabolismLafora DiseaseMouse ModelMolecularMutationEventCarbohydratesDiagnosisMetabolismCessation Of LifePhosphoric Monoester HydrolasesBiochemicalInsightAffectTranslatingComplexNerve DegenerationGenesEpilepsyLifeUbiquitin-Protein LigaseSymptomsSignal Transduction
Grant awards (62)
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential$1,068,798
R35 · FY2025 · NS · contact PI
Targeting Glycogen Metabolism in Ewing's Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications$590,300
R01 · FY2025 · CA
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$531,350
R01 · FY2025 · CA
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential$74,309
R35 · FY2025 · NS · contact PI
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential$1,049,342
R35 · FY2024 · NS · contact PI
Targeting Glycogen Metabolism in Ewing's Sarcoma: Diagnostic, Prognostic, and Therapeutic Applications$600,688
R01 · FY2024 · CA
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$504,786
R01 · FY2024 · CA
Treatment of Lafora disease with an antibody-enzyme fusion$369,812
R33 · FY2024 · NS · contact PI
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential$74,309
R35 · FY2024 · NS · contact PI
Brain Glycogen-Metabolism,Mechanisms, and Therapeutic Potential$1,063,004
R35 · FY2023 · NS · contact PI
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$533,624
R01 · FY2023 · CA
Treatment of Lafora disease with an antibody-enzyme fusion$381,250
R33 · FY2023 · NS · contact PI
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential$74,309
R35 · FY2023 · NS · contact PI
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential$1,147,500
R35 · FY2022 · NS · contact PI
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$496,040
R01 · FY2022 · CA
Aberrant Glycogen in Lung Adenocarcinoma Tumorigenesis$52,466
R01 · FY2022 · CA
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential$23,640
R35 · FY2022 · NS · contact PI
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential$1,147,500
R35 · FY2021 · NS · contact PI
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential$382,500
R35 · FY2021 · NS · contact PI
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential$23,640
R35 · FY2021 · NS · contact PI
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential$1,945
R35 · FY2021 · NS · contact PI
Brain Glycogen - Metabolism, Mechanisms, and Therapeutic Potential$1,048,571
R35 · FY2020 · NS · contact PI
Treatment of Lafora disease with an antibody-enzyme fusion$382,500
R61 · FY2020 · NS · contact PI
Administrative Core$232,265
P01 · FY2020 · NS · contact PI
Core-003$135,000
P01 · FY2020 · NS · contact PI
Personalized diagnosis - defining how glycogen metabolism and proteostasis impact LD$131,829
P01 · FY2020 · NS · contact PI
Lafora Epilepsy - Basic mechanisms to therapy$1,861,448
P01 · FY2019 · NS · contact PI
Personalized diagnosis - defining how glycogen metabolism and proteostasis impact LD$402,773
P01 · FY2019 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases$329,219
R01 · FY2019 · NS · contact PI
Administrative Core$112,556
P01 · FY2019 · NS · contact PI
Lafora Epilepsy - Basic mechanisms to therapy$1,865,054
P01 · FY2018 · NS · contact PI
Personalized diagnosis - defining how glycogen metabolism and proteostasis impact LD$440,752
P01 · FY2018 · NS · contact PI
Alzheimer's disease supplement to NS070899 linking polyglucosans to AD$347,523
R01 · FY2018 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases$329,219
R01 · FY2018 · NS · contact PI
Regulation, Signaling, and Dynamics of Glucan Phosphatases$153,000
R01 · FY2018 · NS · contact PI
Administrative Core$131,538
P01 · FY2018 · NS · contact PI
Lafora Epilepsy - Basic mechanisms to therapy$97,268
P01 · FY2018 · NS · contact PI
Lafora Epilepsy - Basic mechanisms to therapy$1,722,538
P01 · FY2017 · NS · contact PI
Personalized diagnosis - defining how glycogen metabolism and proteostasis impact LD$427,891
P01 · FY2017 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases$329,219
R01 · FY2017 · NS · contact PI
Administrative Core$122,596
P01 · FY2017 · NS · contact PI
Lafora Epilepsy - Basic mechanisms to therapy$1,784,506
P01 · FY2016 · NS · contact PI
Personalized diagnosis - defining how glycogen metabolism and proteostasis impact LD$389,745
P01 · FY2016 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases$329,219
R01 · FY2016 · NS · contact PI
Administrative Core$117,583
P01 · FY2016 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases$306,980
R01 · FY2015 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases$32,897
R01 · FY2015 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases$9,745
R01 · FY2015 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases.$284,921
R01 · FY2014 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases.$277,725
R01 · FY2013 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases.$8,100
R01 · FY2013 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases.$287,799
R01 · FY2012 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases.$287,799
R01 · FY2011 · NS · contact PI
Regulation, signaling, and dynamics of glucan phosphatases.$304,281
R01 · FY2010 · NS · contact PI
THE CONNECTION BETWEEN LAFORA DISEASE AND OTHER POLYGLUCOSAN BODY DISEASES$227,469
P20 · FY2010 · RR · contact PI
Novel Model Systems Link Floridean Starch Metabolism to Lafora Disease$196,174
R00 · FY2010 · NS · contact PI
ROLE OF AMP-ACTIVATED PROTEIN KINASE IN LAFORA AND WOLFF-PARKINSON-WHITE DISEASE$250,004
P20 · FY2009 · RR · contact PI
Novel Model Systems Link Floridean Starch Metabolism to Lafora Disease$192,356
R00 · FY2009 · NS · contact PI
Novel Model Systems Link Floridean Starch Metabolism to Lafora Disease$74,250
R00 · FY2009 · NS · contact PI
Novel Model Systems Link Floridean Starch Metabolism to Lafora Disease$232,725
R00 · FY2008 · NS · contact PI
Use of Novel Model Systems Link Floridean Starch Metabolism to Lafora Disease$77,779
K99 · FY2008 · NS · contact PI
Use of Novel Model Systems Link Floridean Starch Metabolism to Lafora Disease$76,143
K99 · FY2007 · NS · contact PI